Phytochemical Screening and Anticonvulsant Activity of Sebastiania chamaelae

Authors

  • K. Sai Sankeerthana
  • P. Polereddy
  • Vivek V. Byahatti

Abstract

Epilepsy is one of the most common serious neurological conditions. Here, phytochemical screening and anticonvulsant activity of Sebastiania chamaelea evaluated. The present study was undertaken to screen anticonvulsant activity of Sebestiana chamelea. The drug was administered in the form of hydro-alcoholic extract orally and the effect was noted at two doses. The drug was found quite safe by the oral route as animals tolerated drug up to the dose of 2.00 gm. Following interpretations are worth of note in the present study: The drug is quite safe by the oral route as animals tolerated drug up to the dose of 2.00 gm/kg body weight in rats. The drug showed significant antiepileptic activity in both strychnine induced seizures. The antiepileptic effect was more pronounced at a higher dose of the test drug than the lower dose. The drug at a higher dose protected the entire animal from death and percent protection from death in the lower dose was 33%. The present study indicated that Sebestiana chamelea has a potential for developing it as an antiepileptic drug, however more refined studies are needed to evaluate it for exact mechanism of action and chemical constituent of Sebestiana chamalea responsible for the antiepileptic action.

 

Keywords: anticonvulsant activity, antiepileptic activity, phytochemical screening, Sebastiania chamaelae, Wistar Albino rat’s strychnine

 

Cite this Article

K. Sai Sankeerthana, P. Polereddy, Vivek V. Byahatti. Phytochemical Screening and Anticonvulsant Activity of Sebastiania chamaelae. Research & Reviews: A Journal of Pharmacognosy. 2019; 6(3): 23–28p.

Downloads

Published

2020-01-08

Issue

Vol. 6 No. 3 (2019)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.